Research by several PHRI investigators will be presented at the European Society of Cardiology Congress (ESC 2018) in Munich Germany August 25-29, 2018. These presentations will include COMPASS trial results in context of other secondary prevention strategies, and PURE study findings that could influence global dietary guidelines.
Setting the COMPASS into new directions
Presentations on results from the COMPASS trial will happen during ESC 2018 on three separate days:
- Setting the COMPASS into new directions: Satellite Symposium: Presentations by Drs. John Eikelboom and Sonia Anand on improved outcomes for patients with chronic Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD); co-chaired by Dr. Salim Yusuf. August 27, 13:00-14:00.
- Reducing Risk in CAD and PAD. Presentations include Dr. Eikelboom, with opening and closing remarks by Dr. Salim Yusuf. August 28, 10:15-10:45.
- Who will benefit most in CAD? Presentations by Dr. Anand on how to identify patients at risk, and by Dr. Eikelboom on August 26, 16:00 – 16:30.
Dr. Eikelboom is also participating in the Clinical Trial Updates session on August 26, 11:00 – 12:30. He discusses the COMPASS trial – bleeding and cancer risk in patients with vascular disease treated with Rivaroxaban.
How to Eat Right: Should PURE results influence dietary guidelines?
Nutrition, malnutrition and heart disease will be discussed in light of findings from the PURE study on August 27, 14:30-16:00. Dr. Andrew Mente, a principal investigator in Population Health at PHRI, will present on “Going Healthy, Globally: a Comparison of Dietary Patterns.” Dr. Yusuf will moderate a panel discussion with interactive Q&A (mobile app) directed at Dr. Mente as well as other presenters on PURE and diet.
Dr. Mahshid Dehghan, PHRI researcher in nutrition epidemiology, participates in an ESC 2018 session on August 26, 7:30-8:15 about “Fats, Carbs, Alcohol: Debunking the Myths of Healthy Nutrition.”
VISION Study: Frequency, Causes and Timing of 30-Day Mortality after Noncardiac Surgery
Dr. Jessica Spence, PHR researcher, anesthesiology resident at Hamilton Health Sciences and PhD candidate at McMaster University, will participate in Late Breaking Registry Results 1 (a mobile app interactive session) on August 27, 8:30 – 10:00. She will present on the VISION study, looking at the frequency, causes, and timing of 30-day mortality after noncardiac surgery: analysis of the vascular events in noncardiac surgery patients.
MANAGE: Late Breaking Pharmacological Science Session
Dr. PJ Devereaux, Senior Scientific Program Lead, Perioperative, PHRI, will participate in the August 25, 11:00 – 12:30 interactive session on late-breaking pharmacology and pharmacotherapy. He is presenting new results from the MANAGE trial: Dabigatran versus placebo in patients with myocardial injury after noncardiac surgery (MINS).
PACT-HF: Late Breaking Science in Heart Failure
Dr. Harriette Van Spall, a principal investigator in heart failure at PHRI, presents findings from Patient-Centered Care Transitions in Heart Failure (PACT-HF) pragmatic stepped wedge cluster randomized trial during the Late-Breaking Science in Heart Failure session on August 27, 16:45-17:45. She will also participate in the rapid-fire abstract-based programme, Biomarkers reloaded: diagnosis and prognosis of acute heart failure, on the topic of Predicting risk at the point of care: N-terminal prohormone Brain Natriuretic Peptide (NTproBNP) levels improves performance of the LACE index among patients hospitalized for heart failure.
For the full scientific programme at ESC 2018, visit spo.escardio.org.